Quince Therapeutics, Inc.

NasdaqGS:QNCX Stock Report

Market Cap: US$46.2m

Quince Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:QNCX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Dec 23BuyUS$69,233David LamondIndividual67,881US$1.04
07 Dec 23BuyUS$58,134David LamondIndividual57,369US$1.02
01 Dec 23BuyUS$40,546David LamondIndividual43,134US$0.98
31 Aug 23BuyUS$107,898David LamondIndividual82,052US$1.32
17 Aug 23BuyUS$325,737David LamondIndividual250,000US$1.32
10 Aug 23BuyUS$110,880Dirk ThyeIndividual88,000US$1.26
08 Aug 23BuyUS$9,840Margaret McLoughlinIndividual8,000US$1.23
08 Aug 23BuyUS$87,550Brendan HannahIndividual71,762US$1.22
08 Aug 23BuyUS$99,200Dirk ThyeIndividual80,000US$1.24

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of QNCX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies6,7490.0156%
Public Companies189,1220.438%
Hedge Funds3,220,0007.45%
Institutions4,042,0009.35%
VC/PE Firms4,704,10010.9%
Individual Insiders5,817,29313.5%
General Public25,235,96958.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.1%.


Top Shareholders

Top 25 shareholders own 40.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.1%
David Lamond
4,384,096US$4.7m0%no data
7.45%
Tang Capital Management, LLC
3,220,000US$3.4m-7.97%0.39%
5.85%
Genextra S.p.A.
2,525,950US$2.7m0%100.0%
5.04%
Sofinnova Partners SAS
2,178,150US$2.3m0%1.07%
2.25%
The Vanguard Group, Inc.
971,801US$1.0m2.3%no data
2.01%
EPIQ Capital Group, LLC
870,133US$931.0k-6.08%0.41%
1.6%
Dirk Thye
689,441US$737.7k53.6%no data
1.06%
Renaissance Technologies LLC
458,680US$490.8k41.1%no data
0.78%
BlackRock, Inc.
335,604US$359.1k-0.25%no data
0.61%
Geode Capital Management, LLC
261,738US$280.1k19.2%no data
0.47%
Brendan Hannah
201,555US$215.7k0%no data
0.45%
Karen Smith
194,690US$208.3k0%no data
0.44%
Alphabet Inc.
189,122US$202.4k0%no data
0.38%
Merrill Lynch & Co. Inc., Banking Investments
164,818US$176.4k0%no data
0.36%
Chad Boeding
155,773US$166.7k0%no data
0.32%
Bridgeway Capital Management, LLC
138,495US$148.2k0%no data
0.28%
Jane Street Group, LLC, Asset Management Arm
119,741US$128.1k57.8%no data
0.25%
Two Sigma Advisers, LP
110,000US$117.7k-16.6%no data
0.23%
Susquehanna International Group, LLP, Asset Management Arm
100,078US$107.1k-3.75%no data
0.21%
Scharf Investments, LLC
91,061US$97.4k0%no data
0.19%
Luca Benatti
80,261US$85.9k0%no data
0.17%
Mariner, LLC
74,074US$79.3k-1.34%no data
0.17%
Charles Ryan
74,074US$79.3k0%no data
0.14%
Millennium Management LLC
59,447US$63.6k-0.8%no data
0.13%
State Street Global Advisors, Inc.
56,611US$60.6k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.